Peer-reviewed veterinary case report
The potential adjuvanticity of quaternized chitosan hydrogel based microparticles for porcine reproductive and respiratory syndrome virus inactivated vaccine.
- Journal:
- International immunopharmacology
- Year:
- 2016
- Authors:
- Wang, Yue-Qi et al.
- Affiliation:
- Institute of Process Engineering · China
- Species:
- rodent
Plain-English summary
Infectious diseases are a major concern for livestock, and inactivated vaccines are becoming popular because they are safer than live vaccines. However, these inactivated vaccines often don't trigger a strong enough immune response on their own, so an adjuvant (a substance that boosts the immune response) is needed. Researchers created a new type of adjuvant using quaternized chitosan hydrogel microparticles, which are safe and can effectively hold the inactivated vaccine for the porcine reproductive and respiratory syndrome virus (PRRSV). When tested in mice, these microparticles produced a much stronger immune response compared to a commonly used mineral oil-based adjuvant. Overall, the new microparticles showed promise in improving the effectiveness of veterinary vaccines.
Abstract
Infectious diseases possess a big threat to the livestock industry worldwide. Currently, inactivated veterinary vaccines have attracted much attention to prevent infection due to their safer profile compared to live attenuated vaccine. However, its intrinsic poor immunogenicity demands the incorporation of an adjuvant. Mineral oil based adjuvant (Montanide™ ISA206) was usually used to potentiate the efficacy of veterinary vaccines. However, ISA206 could not induce robust cellular immune responses, which was very important in controlling virus replication and clearing the infected cells. Moreover, mineral oil would result in severe side effects. To improve both the humoral and cellular immune responses of porcine reproductive and respiratory syndrome virus (PRRSV) inactivated vaccine, we developed pH-sensitive and size-controllable quaternized chitosan hydrogel microparticles (Gel MPs) without using chemical cross linking agent. Gel MPs, ionic cross-linked with glycerophosphate (GP), were biocompatible and could efficiently adsorb the inactivated PRRSV vaccine with a loading capacity of 579.05μg/mg. After intramuscular immunization in mice, results suggested that Gel MPs elicited significantly higher cell-mediated immune responses and comparable humoral immune responses compared to ISA 206. Regarding the biocompatibility, safety and effectiveness, Gel MPs would be a promising candidate to enhance the efficacy of veterinary vaccine.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/27449471/